You're reading the free version. Trader adds the live tape and alerts.
Start tracking
IAM Conversion Disclosure
Rachlin Evan Lockwood · SEC Form 4 · Filed Oct 19, 2026
Conversion
Calculated transaction value
$0
Rachlin Evan Lockwood Director
IAM
Transaction date
Oct 16, 2026
Public filing date
Oct 19, 2026
Filing lag
Filed 3 days later
IAM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B-3 Convertible Preferred Stock on Common Stock
- Quantity / price
- 306,711 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0002151678-26-000007
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$11.5M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Iambic Therapeutics, Inc. IAM Current | Conversion | Oct 16, 2026 | $0 |
| Iambic Therapeutics, Inc. IAM | Conversion | Oct 16, 2026 | $0 |
| Iambic Therapeutics, Inc. IAM | Conversion | Oct 16, 2026 | $0 |
| Iambic Therapeutics, Inc. IAM | Conversion | Oct 16, 2026 | Not reported |
| Iambic Therapeutics, Inc. IAM | Conversion | Oct 16, 2026 | Not reported |
| Iambic Therapeutics, Inc. IAM | Conversion | Oct 16, 2026 | $0 |
| Iambic Therapeutics, Inc. IAM | Buy | Oct 16, 2026 | $11.5M |
| Iambic Therapeutics, Inc. IAM | Conversion | Oct 16, 2026 | Not reported |